Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
Surial B, Chammartin F, Damas J, Calmy A, Haerry D, Stöckle M, Schmid P, Bernasconi E, Fux CA, Tarr PE, Günthard HF, Wandeler G, Rauch A; Swiss HIV Cohort Study. Surial B, et al. Among authors: damas j. Clin Infect Dis. 2023 Sep 11;77(5):729-737. doi: 10.1093/cid/ciad286. Clin Infect Dis. 2023. PMID: 37157869 Free PMC article. Clinical Trial.
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B, Scherrer AU, Darling KEA, Damas J, Bieler-Aeschlimann M, Hasse B, Schlosser L, Hachfeld A, Gutbrod K, Tarr PE, Calmy A, Assal F, Kunze U, Stoeckle M, Schmid P, Toller G, Rossi S, di Benedetto C, du Pasquier R, Cavassini M, Marzolini C; NAMACO Study Group, a Swiss HIV Cohort Study. Jakeman B, et al. Among authors: damas j. Open Forum Infect Dis. 2022 Sep 2;9(9):ofac457. doi: 10.1093/ofid/ofac457. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36147598 Free PMC article.
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P, Damas J, Viala B, Assal F, Nawej Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling KEA; NAMACO study group, Swiss HIV Cohort Study. Filippidis P, et al. Among authors: damas j. J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):219-228. doi: 10.1097/QAI.0000000000003189. J Acquir Immune Defic Syndr. 2023. PMID: 36927958 Free article.
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M, Frossard J, Kouyos R, Prendki V, Damas J, Hofmann E, Braun D, Schmid P, Bernasconi E, Ragozzino S, Efthimiou O, Delpierre C, Allavena C, Bani-Sadr F, Calmy A; Swiss HIV Cohort Study. Hentzien M, et al. Among authors: damas j. HIV Med. 2024 Jan;25(1):72-82. doi: 10.1111/hiv.13534. Epub 2023 Aug 24. HIV Med. 2024. PMID: 37619609 Free article.
Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
Damas J, Munting A, Fellay J, Haerry D, Marzolini C, Tarr PE, Steffen A, Braun DL, Stoeckle M, Bernasconi E, Tshikung ON, Fux CA, Darling KEA, Béguelin C, Wandeler G, Cavassini M, Surial B; Swiss HIV Cohort Study (SHCS). Damas J, et al. Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093/cid/ciae189. Online ahead of print. Clin Infect Dis. 2024. PMID: 38606792 Free article.
[HIV pre-exposure prophylaxis: physicians are not prepared].
Badoux M, Damas J, Cobos Manuel I, Cavassini M, Munting A. Badoux M, et al. Among authors: damas j. Rev Med Suisse. 2024 Apr 10;20(869):748-755. doi: 10.53738/REVMED.2024.20.869.748. Rev Med Suisse. 2024. PMID: 38616686 French.
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
Damas J, Darling KEA, Bidlingmeyer P, Nadin-Debluë I, Bieler M, Vollino L, Sokolov AA, Berney A, Maccaferri G, Filippidis P, Viala B, Granziera C, Dunet V, Du Pasquier R, Cavassini M. Damas J, et al. HIV Med. 2023 Jun;24(6):738-748. doi: 10.1111/hiv.13472. Epub 2023 Mar 8. HIV Med. 2023. PMID: 36890672
Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A, Damas J, Viala B, Prod'hom G, Guery B, Senn L. Munting A, et al. Among authors: damas j. Antimicrob Resist Infect Control. 2022 Dec 30;11(1):165. doi: 10.1186/s13756-022-01203-x. Antimicrob Resist Infect Control. 2022. PMID: 36585736 Free PMC article.
543 results